Get all your news in one place.
100's of premium titles.
One app.
Start reading
International Business Times
International Business Times
Business
AFP News

Sanofi Pursues Sale Of Painkiller After Political Controversy

Doliprane is France's most widely used medicine to ease mild to moderate pain and fever (Credit: AFP)

Sanofi confirmed on Monday plans to sell a controlling stake in its over-the-counter unit to a US investment fund, after employment and investment guarantees relieved political controversy.

The sale of a controlling 50-percent stake in Opella to CD&R values the maker of France's leading painkiller, Doliprane, at 16 billion euros ($17.4 billion), Sanofi said.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.